Advertisement

Topics

Pharm-Olam International LLC Company Profile

00:37 EDT 17th June 2019 | BioPortfolio

Pharm-Olam International is a multinational Contract Research Organization (CRO) offering comprehensive clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines, making clinical research as Easy As I, II, III, IV™.


News Articles [533 Associated News Articles listed on BioPortfolio]

Pharm-Olam Wins 2019 CRO Leadership Awards

Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology, infectious diseases and vaccines, and rare and orphan diseases, has be...

Pharm-Olam Celebrates 25-Year Anniversary and Announces Enhanced Rare Disease Services

Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology-hematology, infectious diseases and vaccines, and rare diseases, is mar...

Pharm-Olam hits 25 and is still moving forward

Updates to offerings and a rebrand are announced to mark the 25th anniversary of the CRO

Upcoming Pharm-Olam Webinar Helps Sponsors Manage Rescue Study Transitions

Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology-hematology, infectious diseases and vaccines and rare diseases, will be...

Cannbit to sell medical cannabis to Tikun Olam

Tikun Olam will be short of cannabis until its Kfar Yehoshua farms is approved.

Pharm-Olam Enrolls Patients in Zealand Pharma Orphan Drug Study

Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for rare and orphan diseases along with oncology, infectious diseases, and vaccines,...

New patent for Dow Pharm drug BRYHALI

Annual Drug Patent Expirations for BRYHALI Bryhali is a drug marketed by Dow Pharm and is included in one NDA. It is available from one supplier. The generic ingredient in… The post New patent for D...

New patent for Dow Pharm drug ONEXTON

Annual Drug Patent Expirations for ONEXTON Onexton is a drug marketed by Dow Pharm and is included in one NDA. It is available from three suppliers. There are four patents… The post New patent for D...

PubMed Articles [521 Associated PubMed Articles listed on BioPortfolio]

Imidafenacin for treatment of overactive bladder and urgent urinary incontinence: the results of open-label multicenter randomized controlled clinical trial.

The analysis of the results of a multicenter, open, randomized comparative phase III clinical trial on the use of imidafenacin for treating patients with OAB was carried out. A clinical study was cond...

Predicted Amorphous Solubility and Dissolution Rate Advantages Following Moisture Sorption: Case Studies of Indomethacin and Felodipine.

Water is often readily absorbed by amorphous compounds, lowering their glass transition temperature (T) and facilitating their recrystallization (via nucleation-and-growth). At the same time, the incr...

The International Childbirth Initiative: 12 steps to safe and respectful MotherBaby-Family maternity care.

Health promotion by International Olympic Sport Federations: priorities and barriers.

To identify changes in International Federations' priorities and the barriers to implementing athlete and global health initiatives. Results should influence the work of the International Federation m...

History of the International Association of Paediatric Dentistry: A 50-year perspective.

This paper demonstrates how the International Association of Paediatric Dentistry (IAPD) arose from small beginnings in 1967. What started as an International Forum on Child Dental Health in London gr...

Clinical Trials [1202 Associated Clinical Trials listed on BioPortfolio]

Vitamin D Supplementation and and Glycemic Indexes

Age affect insulin sensitivity and the metabolism, and vitamin D status was shown to have a correlation with markers of insulin resistance. That's why, we aimed in our trial to study the e...

Effect of Vitamin D Supplementation on Inflammatory Markers

Previous studies have shown that improving vitamin D status among the elderly may lead to an improvement in some inflammatory markers, especially with patients with type 2 diabetes. The ai...

Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Rivaroxaban from Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Indust...

Vaccination Education Through Pharmacists and Senior Centers (VEPSC)

The study consists of two arms (PHARM and PEER) designed to educate participants about three vaccine-preventable diseases (zoster, pneumonia, and influenza) and vaccination. PHARM will con...

Safety, Reactogenicity, Immunogenicity, and Efficacy of Quadrivalent Inactivated Subunit Influenza Vaccine Grippol® Quadri and Trivalent Inactivated Polymer-Subunit Vaccine Grippol® Plus in Volunteers

The first Russian quadrivalent influenza vaccine was developed to improve the effectiveness of vaccination and the cost-effectiveness of preventive immunization.Current study was conducted...

Companies [1363 Associated Companies listed on BioPortfolio]

Pharm-Olam International Ltd.

Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology...

Pharm-Olam International LLC

Pharm-Olam International is a multinational Contract Research Organization (CRO) offering comprehensive clinical research services to the pharmaceutical, biotechnology and medical...

Pharm-Olam International

Pharm-Olam International started operations in 1994 with the premise of delivering cost-effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, ...

NP Pharm

Founded in January 1992, NP Pharm is a private company, part of the Pharmaceutical group ETHYPHARM, which is one of the world leading companies for Drug Delivery Systems (DDS). Based, on a large exper...

Beijing Med-Pharm Corp

Beijing Med-Pharm offers an end-to-end solution to U.S and western pharmaceutical companies wishing to sell their products in China. We offer sales and marketing services throughout China and can help...

More Information about "Pharm-Olam International LLC" on BioPortfolio

We have published hundreds of Pharm-Olam International LLC news stories on BioPortfolio along with dozens of Pharm-Olam International LLC Clinical Trials and PubMed Articles about Pharm-Olam International LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharm-Olam International LLC Companies in our database. You can also find out about relevant Pharm-Olam International LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...


Corporate Database Quicklinks



Searches Linking to this Company Record